25 XP   0   0   10

AFT Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse AFT Pharmaceuticals Ltd together

PenkeI guess you are interested in AFT Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AFT Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about AFT Pharmaceuticals Ltd

I send you an email if I find something interesting about AFT Pharmaceuticals Ltd.

Quick analysis of AFT Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of AFT Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
A$0.64
Expected worth in 1 year
A$1.03
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.38
Return On Investment
13.6%

For what price can you sell your share?

Current Price per Share
A$2.83
Expected price per share
A$2.5 - A$3
How sure are you?
50%

1. Valuation of AFT Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$2.83

Intrinsic Value Per Share

A$0.59 - A$1.77

Total Value Per Share

A$1.23 - A$2.41

2. Growth of AFT Pharmaceuticals Ltd (5 min.)




Is AFT Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$43.2m$36.7m$6.4m15.0%

How much money is AFT Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$6.2m$11.7m-$5.4m-86.3%
Net Profit Margin6.8%15.2%--

How much money comes from the company's main activities?

3. Financial Health of AFT Pharmaceuticals Ltd (5 min.)




What can you expect buying and holding a share of AFT Pharmaceuticals Ltd? (5 min.)

Welcome investor! AFT Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of AFT Pharmaceuticals Ltd.

What can you expect buying and holding a share of AFT Pharmaceuticals Ltd?

First you should know what it really means to hold a share of AFT Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of AFT Pharmaceuticals Ltd is A$2.83. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AFT Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AFT Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.64. Based on the TTM, the Book Value Change Per Share is A$0.10 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AFT Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.062.1%0.062.1%0.113.9%0.051.8%-0.01-0.3%
Usd Book Value Change Per Share0.062.2%0.062.2%0.145.1%0.072.6%0.041.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share0.062.2%0.062.2%0.145.1%0.082.7%0.041.6%
Usd Price Per Share2.06-2.06-2.13-2.17-1.54-
Price to Earnings Ratio34.28-34.28-19.09-18.28-3.71-
Price-to-Total Gains Ratio33.32-33.32-14.73-0.62--7.01-
Price to Book Ratio4.98-4.98-6.08-19.09-15.36-
Price-to-Total Gains Ratio33.32-33.32-14.73-0.62--7.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.817709
Number of shares550
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.07
Usd Total Gains Per Share0.060.08
Gains per Quarter (550 shares)33.9241.36
Gains per Year (550 shares)135.69165.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101361262163155
202712624326320
304073987490485
405435349653650
5067867011816815
6081480613979980
709509421511431145
80108610781813061310
90122112142014691475
100135713502216321640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%4.06.00.040.0%4.06.00.040.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%8.00.02.080.0%8.00.02.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%6.04.00.060.0%6.04.00.060.0%

Fundamentals of AFT Pharmaceuticals Ltd

About AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2024-04-19 03:07:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of AFT Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit AFT Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.8% means that $0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 6.8%. The company is making a profit. +1
  • The TTM is 6.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.8%TTM6.8%0.0%
TTM6.8%YOY15.2%-8.4%
TTM6.8%5Y7.6%-0.8%
5Y7.6%10Y-5.0%+12.7%
1.1.2. Return on Assets

Shows how efficient AFT Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.2% Return on Assets means that AFT Pharmaceuticals Ltd generated $0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 7.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY15.6%-8.4%
TTM7.2%5Y8.2%-1.0%
5Y8.2%10Y-7.7%+15.8%
1.1.3. Return on Equity

Shows how efficient AFT Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.5% Return on Equity means AFT Pharmaceuticals Ltd generated $0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 14.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY31.9%-17.3%
TTM14.5%5Y18.7%-4.2%
5Y18.7%10Y-25.8%+44.5%

1.2. Operating Efficiency of AFT Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient AFT Pharmaceuticals Ltd is operating .

  • Measures how much profit AFT Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 12.6% means the company generated $0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 12.6%. The company is operating less efficient.
  • The TTM is 12.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.6%TTM12.6%0.0%
TTM12.6%YOY15.6%-3.1%
TTM12.6%5Y11.2%+1.4%
5Y11.2%10Y0.0%+11.1%
1.2.2. Operating Ratio

Measures how efficient AFT Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are $0.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 0.881. The company is less efficient in keeping operating costs low.
  • The TTM is 0.881. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY0.838+0.043
TTM0.8815Y0.877+0.004
5Y0.87710Y1.124-0.247

1.3. Liquidity of AFT Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if AFT Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.38 means the company has $2.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 2.378. The company is able to pay all its short-term debts. +1
  • The TTM is 2.378. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.378TTM2.3780.000
TTM2.378YOY2.669-0.291
TTM2.3785Y2.049+0.330
5Y2.04910Y2.631-0.582
1.3.2. Quick Ratio

Measures if AFT Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.12 means the company can pay off $1.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 1.115. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.115. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.115TTM1.1150.000
TTM1.115YOY1.301-0.186
TTM1.1155Y0.994+0.122
5Y0.99410Y1.338-0.344

1.4. Solvency of AFT Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of AFT Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AFT Pharmaceuticals Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that AFT Pharmaceuticals Ltd assets are financed with 50.5% credit (debt) and the remaining percentage (100% - 50.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 0.505. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.505. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.505TTM0.5050.000
TTM0.505YOY0.511-0.005
TTM0.5055Y0.678-0.173
5Y0.67810Y0.731-0.053
1.4.2. Debt to Equity Ratio

Measures if AFT Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 102.1% means that company has $1.02 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AFT Pharmaceuticals Ltd:

  • The MRQ is 1.021. The company is able to pay all its debts with equity. +1
  • The TTM is 1.021. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.021TTM1.0210.000
TTM1.021YOY1.043-0.023
TTM1.0215Y3.895-2.874
5Y3.89510Y3.684+0.211

2. Market Valuation of AFT Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings AFT Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare AFT Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 34.28 means the investor is paying $34.28 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AFT Pharmaceuticals Ltd:

  • The EOD is 30.317. Based on the earnings, the company is overpriced. -1
  • The MRQ is 34.281. Based on the earnings, the company is overpriced. -1
  • The TTM is 34.281. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.317MRQ34.281-3.964
MRQ34.281TTM34.2810.000
TTM34.281YOY19.091+15.190
TTM34.2815Y18.277+16.004
5Y18.27710Y3.713+14.563
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AFT Pharmaceuticals Ltd:

  • The EOD is 28.254. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 31.948. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 31.948. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD28.254MRQ31.948-3.694
MRQ31.948TTM31.9480.000
TTM31.948YOY27.413+4.535
TTM31.9485Y-0.900+32.848
5Y-0.90010Y-6.165+5.265
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of AFT Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of AFT Pharmaceuticals Ltd:

  • The EOD is 4.408. Based on the equity, the company is fair priced.
  • The MRQ is 4.985. Based on the equity, the company is fair priced.
  • The TTM is 4.985. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.408MRQ4.985-0.576
MRQ4.985TTM4.9850.000
TTM4.985YOY6.081-1.097
TTM4.9855Y19.092-14.107
5Y19.09210Y15.363+3.729
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AFT Pharmaceuticals Ltd.

3.1. Funds holding AFT Pharmaceuticals Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-02-28Commonwealth International Ser-Australia/New Zealand Fund0.04-46000--
Total 0.0404600000.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of AFT Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0960.0960%0.225-57%0.116-17%0.064+50%
Book Value Per Share--0.6420.6420%0.546+18%0.341+88%0.221+191%
Current Ratio--2.3782.3780%2.669-11%2.049+16%2.631-10%
Debt To Asset Ratio--0.5050.5050%0.511-1%0.678-25%0.731-31%
Debt To Equity Ratio--1.0211.0210%1.043-2%3.895-74%3.684-72%
Dividend Per Share----0%-0%0.002-100%0.004-100%
Eps--0.0930.0930%0.174-46%0.081+15%-0.011+112%
Free Cash Flow Per Share--0.1000.1000%0.121-17%0.035+190%-0.027+127%
Free Cash Flow To Equity Per Share--0.0390.0390%0.101-61%0.013+192%0.014+173%
Gross Profit Margin---2.593-2.5930%-0.523-80%0.977-365%1.502-273%
Intrinsic Value_10Y_max--1.768--------
Intrinsic Value_10Y_min--0.591--------
Intrinsic Value_1Y_max--0.084--------
Intrinsic Value_1Y_min--0.041--------
Intrinsic Value_3Y_max--0.323--------
Intrinsic Value_3Y_min--0.140--------
Intrinsic Value_5Y_max--0.648--------
Intrinsic Value_5Y_min--0.256--------
Market Cap296770780.000-13%335571200.000335571200.0000%348155120.000-4%354132482.000-5%250891905.000+34%
Net Profit Margin--0.0680.0680%0.152-55%0.076-11%-0.050+174%
Operating Margin--0.1260.1260%0.156-20%0.112+12%0.000+61757%
Operating Ratio--0.8810.8810%0.838+5%0.877+0%1.124-22%
Pb Ratio4.408-13%4.9854.9850%6.081-18%19.092-74%15.363-68%
Pe Ratio30.317-13%34.28134.2810%19.091+80%18.277+88%3.713+823%
Price Per Share2.830-13%3.2003.2000%3.320-4%3.377-5%2.393+34%
Price To Free Cash Flow Ratio28.254-13%31.94831.9480%27.413+17%-0.900+103%-6.165+119%
Price To Total Gains Ratio29.471-13%33.32433.3240%14.733+126%0.615+5315%-7.012+121%
Quick Ratio--1.1151.1150%1.301-14%0.994+12%1.338-17%
Return On Assets--0.0720.0720%0.156-54%0.082-12%-0.077+206%
Return On Equity--0.1450.1450%0.319-54%0.187-22%-0.258+277%
Total Gains Per Share--0.0960.0960%0.225-57%0.117-18%0.068+41%
Usd Book Value--43238761.44443238761.4440%36770769.614+18%22957830.126+88%14861239.997+191%
Usd Book Value Change Per Share--0.0620.0620%0.145-57%0.074-17%0.041+50%
Usd Book Value Per Share--0.4120.4120%0.351+18%0.219+88%0.142+191%
Usd Dividend Per Share----0%-0%0.001-100%0.003-100%
Usd Eps--0.0600.0600%0.112-46%0.052+15%-0.007+112%
Usd Free Cash Flow--6746540.3846746540.3840%8157577.653-17%2330011.437+190%-1446969.670+121%
Usd Free Cash Flow Per Share--0.0640.0640%0.078-17%0.022+190%-0.017+127%
Usd Free Cash Flow To Equity Per Share--0.0250.0250%0.065-61%0.009+192%0.009+173%
Usd Market Cap190615871.994-13%215537381.760215537381.7600%223620033.576-4%227459293.189-5%161147870.582+34%
Usd Price Per Share1.818-13%2.0552.0550%2.132-4%2.169-5%1.537+34%
Usd Profit--6287407.3876287407.3870%11713202.724-46%5730192.251+10%-501697.355+108%
Usd Revenue--92440940.53992440940.5390%76904186.805+20%69699575.686+33%53249293.071+74%
Usd Total Gains Per Share--0.0620.0620%0.145-57%0.075-18%0.044+41%
 EOD+4 -4MRQTTM+0 -0YOY+9 -255Y+20 -1610Y+28 -8

4.2. Fundamental Score

Let's check the fundamental score of AFT Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.317
Price to Book Ratio (EOD)Between0-14.408
Net Profit Margin (MRQ)Greater than00.068
Operating Margin (MRQ)Greater than00.126
Quick Ratio (MRQ)Greater than11.115
Current Ratio (MRQ)Greater than12.378
Debt to Asset Ratio (MRQ)Less than10.505
Debt to Equity Ratio (MRQ)Less than11.021
Return on Equity (MRQ)Greater than0.150.145
Return on Assets (MRQ)Greater than0.050.072
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of AFT Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.830
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets148,063
Total Liabilities74,795
Total Stockholder Equity73,268
 As reported
Total Liabilities 74,795
Total Stockholder Equity+ 73,268
Total Assets = 148,063

Assets

Total Assets148,063
Total Current Assets94,600
Long-term Assets19,533
Total Current Assets
Cash And Cash Equivalents 4,749
Net Receivables 39,618
Inventory 42,397
Other Current Assets 7,836
Total Current Assets  (as reported)94,600
Total Current Assets  (calculated)94,600
+/- 0
Long-term Assets
Property Plant Equipment 3,365
Intangible Assets 16,168
Long-term Assets Other -19,533
Long-term Assets  (as reported)19,533
Long-term Assets  (calculated)0
+/- 19,533

Liabilities & Shareholders' Equity

Total Current Liabilities39,775
Long-term Liabilities32,200
Total Stockholder Equity73,268
Total Current Liabilities
Short-term Debt 3,029
Short Long Term Debt 2,458
Accounts payable 22,185
Other Current Liabilities 17,590
Total Current Liabilities  (as reported)39,775
Total Current Liabilities  (calculated)45,262
+/- 5,487
Long-term Liabilities
Capital Lease Obligations 3,391
Deferred Long Term Liability 29,459
Long-term Liabilities  (as reported)32,200
Long-term Liabilities  (calculated)32,850
+/- 650
Total Stockholder Equity
Common Stock81,406
Retained Earnings -5,198
Accumulated Other Comprehensive Income 226
Other Stockholders Equity -3,166
Total Stockholder Equity (as reported)73,268
Total Stockholder Equity (calculated)73,268
+/-0
Other
Capital Stock78,240
Cash and Short Term Investments 4,749
Common Stock Shares Outstanding 104,849
Current Deferred Revenue-3,029
Liabilities and Stockholders Equity 148,063
Net Debt 33,300
Net Invested Capital 107,926
Net Tangible Assets 57,100
Net Working Capital 54,825
Property Plant and Equipment Gross 3,365
Short Long Term Debt Total 38,049



Balance Sheet

Currency in NZD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
25,467
33,213
58,832
58,231
56,603
63,595
87,052
105,132
127,324
148,063
148,063127,324105,13287,05263,59556,60358,23158,83233,21325,467
   > Total Current Assets 
23,643
30,725
55,905
54,060
48,312
51,261
55,336
67,902
77,542
94,600
94,60077,54267,90255,33651,26148,31254,06055,90530,72523,643
       Cash And Cash Equivalents 
1,242
4,700
25,275
15,980
6,770
6,916
6,119
3,209
7,940
4,749
4,7497,9403,2096,1196,9166,77015,98025,2754,7001,242
       Net Receivables 
8,696
10,536
13,915
17,403
14,779
16,278
22,627
29,227
29,866
39,618
39,61829,86629,22722,62716,27814,77917,40313,91510,5368,696
       Inventory 
12,654
14,686
15,933
18,718
24,412
25,158
22,734
33,654
33,500
42,397
42,39733,50033,65422,73425,15824,41218,71815,93314,68612,654
   > Long-term Assets 
0
0
2,927
4,171
8,291
12,334
19,489
19,374
19,348
19,533
19,53319,34819,37419,48912,3348,2914,1712,92700
       Property Plant Equipment 
405
411
367
386
330
357
4,027
3,786
3,360
3,365
3,3653,3603,7864,027357330386367411405
       Long Term Investments 
0
0
185
627
2,135
3,033
0
0
0
0
00003,0332,13562718500
       Intangible Assets 
1,419
1,669
1,902
2,548
5,118
8,239
15,462
15,588
15,988
16,168
16,16815,98815,58815,4628,2395,1182,5481,9021,6691,419
       Other Assets 
0
408
546
610
3,173
6,030
12,227
17,856
30,434
33,930
33,93030,43417,85612,2276,0303,1736105464080
> Total Liabilities 
22,419
31,192
33,400
38,761
49,261
58,504
69,797
68,544
65,016
74,795
74,79565,01668,54469,79758,50449,26138,76133,40031,19222,419
   > Total Current Liabilities 
9,282
10,453
12,534
15,335
18,607
58,504
25,102
32,102
29,050
39,775
39,77529,05032,10225,10258,50418,60715,33512,53410,4539,282
       Short-term Debt 
13,137
20,739
23,161
23,426
30,654
41,750
2,506
5,775
4,542
3,029
3,0294,5425,7752,50641,75030,65423,42623,16120,73913,137
       Short Long Term Debt 
13,137
20,739
23,161
23,426
30,654
41,750
2,000
5,161
4,000
2,458
2,4584,0005,1612,00041,75030,65423,42623,16120,73913,137
       Accounts payable 
6,291
5,661
7,333
7,348
7,335
6,673
8,622
14,703
12,068
22,185
22,18512,06814,7038,6226,6737,3357,3487,3335,6616,291
       Other Current Liabilities 
0
1,849
5,201
7,987
11,272
10,081
16,480
17,399
16,982
17,590
17,59016,98217,39916,48010,08111,2727,9875,2011,8490
   > Long-term Liabilities 
0
0
20,866
23,426
30,654
44,695
41,200
33,200
33,200
32,200
32,20033,20033,20041,20044,69530,65423,42620,86600
       Long term Debt Total 
0
0
0
0
30,654
0
44,695
36,442
0
0
0036,44244,695030,6540000
       Other Liabilities 
0
0
0
0
0
0
0
3,242
0
0
003,2420000000
       Deferred Long Term Liability 
0
0
0
0
2,465
5,325
11,522
17,132
22,105
29,459
29,45922,10517,13211,5225,3252,4650000
> Total Stockholder Equity
3,048
-11,873
25,432
19,470
7,342
5,091
17,255
36,588
62,308
73,268
73,26862,30836,58817,2555,0917,34219,47025,432-11,8733,048
   Common Stock
33
41
48,560
53,820
63,743
63,743
57,061
80,359
80,770
81,406
81,40680,77080,35957,06163,74363,74353,82048,5604133
   Retained Earnings 
3,012
-10,732
-23,096
-44,025
-57,644
-61,006
-49,275
-41,264
-15,852
-5,198
-5,198-15,852-41,264-49,275-61,006-57,644-44,025-23,096-10,7323,012
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
3
-1,182
0
10,719
-9,124
3,577
-4,108
-3,162
-3,164
-3,166
-3,166-3,164-3,162-4,1083,577-9,12410,7190-1,1823



Balance Sheet

Currency in NZD. All numbers in thousands.




Cash Flow

Currency in NZD. All numbers in thousands.




Income Statement

Currency in NZD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue156,641
Cost of Revenue-83,658
Gross Profit72,98372,983
 
Operating Income (+$)
Gross Profit72,983
Operating Expense-54,324
Operating Income19,66918,659
 
Operating Expense (+$)
Research Development6,447
Selling General Administrative11,123
Selling And Marketing Expenses38,279
Operating Expense54,32455,849
 
Net Interest Income (+$)
Interest Income13
Interest Expense-2,873
Other Finance Cost-0
Net Interest Income-2,860
 
Pretax Income (+$)
Operating Income19,669
Net Interest Income-2,860
Other Non-Operating Income Expenses-
Income Before Tax (EBT)15,79923,539
EBIT - interestExpense = 16,796
15,799
13,527
Interest Expense2,873
Earnings Before Interest and Taxes (EBIT)19,66918,672
Earnings Before Interest and Taxes (EBITDA)19,879
 
After tax Income (+$)
Income Before Tax15,799
Tax Provision-5,145
Net Income From Continuing Ops10,65410,654
Net Income10,654
Net Income Applicable To Common Shares10,654
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses137,982
Total Other Income/Expenses Net-3,8702,860
 

Technical Analysis of AFT Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AFT Pharmaceuticals Ltd. The general trend of AFT Pharmaceuticals Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AFT Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AFT Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3 < 3 < 3.

The bearish price targets are: 2.5 > 2.5.

Tweet this
AFT Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AFT Pharmaceuticals Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AFT Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAFT Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AFT Pharmaceuticals Ltd. The current adx is .

AFT Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartAFT Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Stochastic Oscillator ChartAFT Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartAFT Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartAFT Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Williams %R ChartAFT Pharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Average True Range (ATR) ChartAFT Pharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartAFT Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartAFT Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AFT Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

AFT Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AFT Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.830
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of AFT Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on AFT Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AFT Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AFT Pharmaceuticals Ltd

I send you an email if I find something interesting about AFT Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about AFT Pharmaceuticals Ltd.

Receive notifications about AFT Pharmaceuticals Ltd in your mailbox!